| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 01/30/2002 | EP1175227A1 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 01/30/2002 | EP1175212A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity |
| 01/30/2002 | CN1078480C Somatostatin binding peptide-metal chelate conjugates |
| 01/29/2002 | US6342392 Isolation of human and murine wild-type int6 gene cdna; cancer diagnosis; gene and immunotherapy; vaccines; gene expression |
| 01/29/2002 | US6342201 Complex compounds for diagnosis of vascular diseases |
| 01/24/2002 | WO2002006515A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/24/2002 | WO2002006248A2 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 01/24/2002 | WO2002006213A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 01/24/2002 | WO2002005860A1 Radioligand and binding assay |
| 01/24/2002 | WO2002005859A2 Radiotherapy |
| 01/24/2002 | WO2001053324A3 Novel haptotactic peptides |
| 01/24/2002 | WO2001039744A3 Radiation sensitive liposomes |
| 01/24/2002 | WO2001036005A3 Targeted delivery of therapeutic and diagnostic moieties |
| 01/24/2002 | WO2001023385A3 Novel tropane analogs |
| 01/24/2002 | US20020010325 Complexing; purified polypeptide |
| 01/24/2002 | US20020010207 Tropane analogs and methods for inhibition of monoamine transport |
| 01/24/2002 | US20020010177 For treating eosinophil-dependent inflammatory diseases, asthma |
| 01/24/2002 | US20020009444 Brain disorders using monoclonal antibodies |
| 01/24/2002 | US20020009416 Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system |
| 01/24/2002 | US20020009415 Microspheres for use in the treatment of cancer |
| 01/24/2002 | CA2416285A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/24/2002 | CA2415932A1 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 01/23/2002 | EP1174441A2 Antibodies and fv fragment recognizing antigen ior c2 |
| 01/23/2002 | EP1173765A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 01/23/2002 | EP1173480A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173252A1 Products and methods for brachytherapy |
| 01/23/2002 | EP1173226A2 Fatty acid analogs for diagnosis of coronary artery disease |
| 01/23/2002 | EP1173224A1 Polyethyleneimine:dna formulations for aerosol delivery |
| 01/23/2002 | EP1173192A2 Methods and compositions for targeted drug delivery |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004030A2 Stable radiopharmaceutical compositions |
| 01/17/2002 | WO2002004021A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | WO2001082974A3 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
| 01/17/2002 | WO2001010468A3 Drug-carrier complexes and methods of use thereof |
| 01/17/2002 | US20020006404 Treatment of cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | US20020006379 Diagnosis of tissue damage, cancer |
| 01/17/2002 | CA2415100A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | CA2414219A1 Lipid metabolism molecules |
| 01/17/2002 | CA2413538A1 Stable radiopharmaceutical compositions and methods for preparation thereof |
| 01/16/2002 | EP1171469A1 ANTI-p53 ANTIBODIES |
| 01/16/2002 | EP1171468A2 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 01/16/2002 | EP1171441A1 Morphinoid compounds |
| 01/16/2002 | EP1171166A1 Benzodiazepine derivatives for imaging thrombi |
| 01/16/2002 | EP1171162A2 Cobalamin conjugates useful as antitumor agents |
| 01/16/2002 | EP1019095B1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
| 01/16/2002 | EP0697875B1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 01/16/2002 | CN1331592A Liposomic niflumic acid-new transdermal anti-inflammatory medicine |
| 01/16/2002 | CN1331081A Tetraphosphine quatorphosphonium salt, its preparing process, and two-step tetraphosphine medicine kit and its application |
| 01/15/2002 | US6339716 Method for determining viability of a myocardial segment |
| 01/15/2002 | US6339079 Steroid sulfamates, method for the production and use thereof |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/15/2002 | US6338835 Radioprotectant for peptides labeled with radioisotope |
| 01/15/2002 | US6338834 Radionucleotide directly bonding to alpha-melanotropin stimulating hormone for diagnosis |
| 01/15/2002 | US6338810 Method for making apatite ceramics, in particular for biological use |
| 01/10/2002 | WO2002002150A2 Stable radioiodine conjugates and methods for their synthesis |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001025410A3 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 01/10/2002 | US20020004032 Macrocyclic chelants for metallopharmaceuticals |
| 01/10/2002 | US20020004031 Process for therapeutic treatment of proliferative diseases |
| 01/10/2002 | US20020004030 Extracorporal system for treating disease with radionucleotides |
| 01/10/2002 | DE10028056A1 Process and apparatus for production of carrier-free 72As useful as component of positron emission tomography pharmaceuticals |
| 01/09/2002 | EP1169066A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 01/09/2002 | EP1169064A2 Method of detecting endometriosis |
| 01/09/2002 | EP1169046A1 Pulmonary delivery of protonated/acidified nucleic acids |
| 01/09/2002 | CN1330664A Platelet-derived growth factor C, DNA coding therefor and uses thereof |
| 01/09/2002 | CN1330643A IL-5 inhibiting azauracil pyrimidine derivatives |
| 01/09/2002 | CN1077440C Radioactive rhenium marking tin-sulphur colloid agent, prepn. method and use therefor |
| 01/09/2002 | CN1077439C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 01/08/2002 | CA2003880C Radiopharmaceutical compound having a cardiac tropism comprising a nitruro complex of a transition metal and preparation process of the same |
| 01/03/2002 | WO2002000603A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 01/03/2002 | WO2002000193A2 Multiple stimulus reversible hydrogels |
| 01/03/2002 | WO2002000170A2 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 01/03/2002 | WO2001028587A3 Magnetic targeted carrier |
| 01/03/2002 | WO2001021218A3 Method for determining viability of a myocardial segment |
| 01/03/2002 | US20020002134 PAI-2 conjugates for the treatment and imaging of cancer |
| 01/03/2002 | US20020001566 Pharmaceuticals for the imaging of angiogenic disorders |
| 01/03/2002 | CA2414401A1 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 01/03/2002 | CA2412568A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 01/03/2002 | CA2412017A1 Multiple stimulus reversible hydrogels |
| 01/02/2002 | EP1165147A1 Assessment of gastric emptying disorders |
| 01/02/2002 | EP1165146A1 Lipid soluble radioactive metal chelates for tumor therapy |
| 01/02/2002 | EP1165137A1 Sphingomyelin containing preparation for the enhancement of tumor therapy |
| 01/02/2002 | EP1165134A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 01/02/2002 | EP0722457B1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 01/02/2002 | CN2468490Y Installation for prodn. of fluorine-18 making drug |
| 01/02/2002 | CN1329504A F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 01/01/2002 | US6335465 Sterilized 5-aminolevulinic acid |
| 01/01/2002 | US6334996 Radiolabels for targeting specific diagnostic pharmaceuticals |
| 01/01/2002 | US6334995 Process for the preparation of technetium-99m diethylene triamine penta-acetic acid diester |
| 12/27/2001 | WO2001098543A2 Method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 12/27/2001 | WO2001098329A1 Polyhydroxy glycopeptide derivatives |
| 12/27/2001 | WO2001098328A2 Glycopeptide phosphonate derivatives |
| 12/27/2001 | WO2001098327A2 Glycopeptide carboxy-saccharide derivatives |
| 12/27/2001 | WO2001098326A2 Glycopeptide disulfide and thioester derivatives |
| 12/27/2001 | WO2001097863A1 PREPARATIONS FOR MEASURING GASTRIC pH VALUE AND METHOD OF MEASURING GASTRIC pH VALUE BY USING THE SAME |
| 12/27/2001 | WO2001097862A2 Stabiliser for radiopharmaceuticals |
| 12/27/2001 | WO2001097861A2 Vitronectin receptor antagonist pharmaceuticals |
| 12/27/2001 | WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | WO2001097859A1 Liposomal encapsulation of chelated actinium-225 and uses thereof |